| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $170K | -98.5% |
| R&D Expense | $12.8M | +40.6% |
| SG&A Expense | $11.6M | +131.2% |
| Operating Income | -$24.2M | -702.0% |
| Income Tax | $1.1M | +0.0% |
| Net Income | -$28.3M | -443.4% |
| EPS (Basic) | -$1.16 | -103.5% |
| EPS (Diluted) | -$1.16 | -103.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.4M | +2272.3% |
| Short-term Investments | $13.8M | — |
| Current Assets | $24.2M | +1179.2% |
| Total Assets | $27.9M | +404.3% |
| Current Liabilities | $6.6M | -79.3% |
| Total Liabilities | $8.4M | -79.6% |
| Stockholders' Equity | $19.5M | +154.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.3M | -467.8% |
| Capital Expenditures | $1.0M | +1991.8% |
| Investing Cash Flow | -$14.7M | — |
| Financing Cash Flow | $44.0M | +9309.2% |
| Free Cash Flow | -$21.3M | -488.4% |